De Novo Donor-Specific HLA Antibody Development and Peripheral Cells in Kidney Transplant Recipients: A Place for Interaction?
Figure 2
(a) Graft survival according to DSA development during the first year post-KT; DSA+ve versus DSA−ve, . (b) Graft survival according to class I DSA development during the first year post-KT, . Treg numbers (c) and percentages (d) at different time points during the first year post-KT in patients who developed DSA and those who remained DSA−ve. At 12 months, the difference in Treg numbers and percentages was significantly different between DSA+ve versus DSA−ve patients, , and , respectively.